Gold's work demonstrated hydrazine sulfate's ability to slow and reverse cachexia in advanced cancer patients. Yet many starving cancer patients are offered either no nutritional support or the standard TPN solution developed for intensive care units. The solution provides 70 percent of the calories going into the bloodstream in the form of glucose. All too often, I believe, these high-glucose solutions for cachectic cancer patients do not help as much as would TPN solutions with lower levels of glucose and higher levels of amino acids and lipids. These solutions would allow the patient to build strength and would not feed the tumor.17 The medical establishment may be missing the connection between sugar and its role in tumorigenesis.
PET scans use radioactively labeled glucose to detect sugar-hungry tumor cells.
Conceived by Manfred von Ardenne in Germany in 1965, SCMT entails injecting patients with glucose to increase blood-glucose concentrations. In turn, this intensifies the thermal sensitivity of the malignant tumors and also induces rapid growth of the cancer. I study at the Von Ardenne Institute of Applied Medical Research in Dresden, Germany. The protocol induces rapid growth of the cancer, then treats the tumor with toxic therapies for a dramatic improvement in outcome. The irrefutable role of glucose in the growth and metastasis of cancer cells can enhance many therapies.